Impact of Clinical Pharmacist in Collaboration with Physicians in Minimizing Drug Therapy Problems among Hypertension and Diabetes Mellitus

It is estimated that one in six people worldwide, or nearly one billion, are affected by high blood pressure(1).7.6 million deaths per annum worldwide(1). Globally, an estimated 462 million individuals are affected by type 2 diabetes, corresponding to 6.28% of the world's population(2). More than 1 million deaths were attributed to this condition in 2017 alone, ranking it as the ninth leading cause of mortality(2). The clinical pharmacist’s role is to assess the status of the patient's health problems and determine whether the prescribed medications are optimally meeting the patient's needs and goals of care(3). To study the impact of Clinical pharmacists in collaboration with Physicians in minimizing drug-therapy problems among Hypertension and Type 2 Diabetes Mellitus. A Prospective interventional study was carried out at Sangareddy District Government Hospital for a period of 6 months. A structured proforma was designed to collect patient data. Descriptive analysis was analyzed using MS Excel 2019 MSO to describe demographics, Drug-Related problems, Clinical pharmacist -Physician Intervention, Antihypertensive Drugs, and oral hypoglycemic drug usage. Out of 133 study individuals, the majority of subjects had a Sub-therapeutic goal (44%), followed by an Inappropriate Drug[41%]. The majority of patients had at least one DRP(82%). The most common Intervention performed was the addition of appropriate drugs(31%), followed by cessation of drugs(30%). Our study concludes that the collaboration of Clinical Pharmacists with Physicians can assist in identifying and preventing drug-related problems through interventions and their expertise in pharmacotherapy can assist in providing rational drug therapy.